Health Catalyst
HCAT
168 hedge funds and large institutions have $1.76B invested in Health Catalyst in 2020 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 65 increasing their positions, 43 reducing their positions, and 10 closing their positions.
1,368% more call options, than puts
Call options by funds: $8.49M | Put options by funds: $578K
320% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 10
51% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 43
22% more funds holding
Funds holding: 138 → 168 (+30)
20% more capital invested
Capital invested by funds: $1.46B → $1.76B (+$293M)
5.74% less ownership
Funds ownership: 100.77% → 95.03% (-5.7%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$37.8M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$26.6M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$13.4M |
| 4 |
BlackRock
New York
|
+$11.4M |
| 5 |
ClearBridge Investments
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$86.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.1M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$6.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.28M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$5.02M |
HCAT Hedge Fund Activity: Q4 2020 in Review
168 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q4 2020, worth a combined $1.76B — up 20% from $1.46B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new HCAT positions and 10 closed out — a net gain of 32 holders — while 65 added to existing stakes and 43 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $37.8M. The largest seller was Wells Fargo, cutting an estimated $86.2M.
- 168 institutional investors held Health Catalyst (HCAT) as of Q4 2020, up from 138 in Q3 2020.
- Funds reported $1.76B of Health Catalyst stock for Q4 2020, up 20% quarter-over-quarter.
- 42 funds opened new Health Catalyst positions in Q4 2020 and 10 closed out, a net change of +32 holders.
- The largest Health Catalyst buyer in Q4 2020 was Fidelity Investments, an estimated $37.8M added.
- The largest Health Catalyst seller in Q4 2020 was Wells Fargo, an estimated $86.2M sold.
Based on aggregated 13F filings for Q4 2020.